Search results for: 'Drug Discovery and Early Development Outsourcing Services'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...

This Frost & Sullivan research service offers an analysis of the information and communications technology (ICT) services market, providing market sizing and forecasts by service, in terms of revenue. Frost & Sullivan presents an in-depth analysis of the following markets: fixed telephony, enterprise data communications, fixed broadband, pay-TV, mo...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

This Frost & Sullivan research service provides market sizing and forecasts by segment and technology, both in terms of lines and revenues and market share figures. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: fixed telephony, data communications (VPN IP MPLS, Carrier Ethernet, and other technologie...

European economies had a challenging 2022 due to the onset of the Russo-Ukrainian War and the heightened inflationary pressure. The war impacted national security and weighed heavily on regional companies' economic performance. Historic price levels mandated monetary policy tightening as energy and fuel prices reduced consumer spending. Moreover, r...

27 Oct 2021  |  Asia Pacific  |  Frost Radar

Frost Radar™ for Economic Development: Broader Asia, 2021

Australia, South Korea, and New Zealand Emerge as the Broader Asian Leaders

Infographics

×

Key Issues Addressed

The Frost Radar™ for Economic Development determines a region's future growth and development potential measured by its ability to enhance citizen satisfaction of quality of life. This report explores Broader Asia’s strengths and weaknesses through country-level assessments of growth and innovation initiatives and benchmarks each country on these t...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...